Rash Risk After Aminopenicillins in Mono Lower Than Expected
A new systematic review and meta-analysis reveals that the risk of rash in patients with infectious mononucleosis (IM) who are prescribed aminopenicillins is significantly lower than long believed, challenging decades-old assumptions in clinical practice.